These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25616537)

  • 1. Spacers in radiotherapy treatment of prostate cancer: is reduction of toxicity cost-effective?
    Vanneste BG; Pijls-Johannesma M; Van De Voorde L; van Lin EN; van de Beek K; van Loon J; Ramaekers BL; Lambin P
    Radiother Oncol; 2015 Feb; 114(2):276-81. PubMed ID: 25616537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of SBRT versus IMRT for low-risk prostate cancer.
    Sher DJ; Parikh RB; Mays-Jackson S; Punglia RS
    Am J Clin Oncol; 2014 Jun; 37(3):215-21. PubMed ID: 23275277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A decision model to estimate the cost-effectiveness of intensity modulated radiation therapy (IMRT) compared to three dimensional conformal radiation therapy (3DCRT) in patients receiving radiotherapy to the prostate bed.
    Carter HE; Martin A; Schofield D; Duchesne G; Haworth A; Hornby C; Sidhom M; Jackson M
    Radiother Oncol; 2014 Aug; 112(2):187-93. PubMed ID: 24929702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of intensity-modulated radiotherapy in prostate cancer.
    Yong JH; Beca J; McGowan T; Bremner KE; Warde P; Hoch JS
    Clin Oncol (R Coll Radiol); 2012 Sep; 24(7):521-31. PubMed ID: 22705100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of intensity-modulated radiation therapy with normal and hypofractionated schemes for the treatment of localised prostate cancer.
    Zemplényi AT; Kaló Z; Kovács G; Farkas R; Beöthe T; Bányai D; Sebestyén Z; Endrei D; Boncz I; Mangel L
    Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 26782759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity and cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for postoperative treatment of gynecologic cancers.
    Chen LA; Kim J; Boucher K; Terakedis B; Williams B; Nickman NA; Gaffney DK
    Gynecol Oncol; 2015 Mar; 136(3):521-8. PubMed ID: 25562668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protons in head-and-neck cancer: bridging the gap of evidence.
    Ramaekers BL; Grutters JP; Pijls-Johannesma M; Lambin P; Joore MA; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1282-8. PubMed ID: 23273998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation.
    Hummel S; Simpson EL; Hemingway P; Stevenson MD; Rees A
    Health Technol Assess; 2010 Oct; 14(47):1-108, iii-iv. PubMed ID: 21029717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus 3-Dimensional Conformal Radiation Therapy for Preoperative Treatment of Extremity Soft Tissue Sarcomas.
    Richard P; Phillips M; Smith W; Davidson D; Kim E; Kane G
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(3):999-1008. PubMed ID: 27130792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer.
    Konski A; Watkins-Bruner D; Feigenberg S; Hanlon A; Kulkarni S; Beck JR; Horwitz EM; Pollack A
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):408-15. PubMed ID: 16887291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a virtual spacer to support the decision for the placement of an implantable rectum spacer for prostate cancer radiotherapy: Comparison of dose, toxicity and cost-effectiveness.
    van Wijk Y; Vanneste BGL; Walsh S; van der Meer S; Ramaekers B; van Elmpt W; Pinkawa M; Lambin P
    Radiother Oncol; 2017 Oct; 125(1):107-112. PubMed ID: 28823404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model of the cost-effectiveness of intensity-modulated radiotherapy in comparison with three-dimensional conformal radiotherapy for the treatment of localised prostate cancer.
    Hummel SR; Stevenson MD; Simpson EL; Staffurth J
    Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e159-67. PubMed ID: 23040143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity-modulated radiation therapy (IMRT) versus 3-dimensional conformal radiation therapy (3D-CRT) for head and neck cancer: cost-effectiveness analysis.
    Marta GN; Weltman E; Ferrigno R
    Rev Assoc Med Bras (1992); 2018 Apr; 64(4):318-323. PubMed ID: 30133610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is proton beam therapy cost effective in the treatment of adenocarcinoma of the prostate?
    Konski A; Speier W; Hanlon A; Beck JR; Pollack A
    J Clin Oncol; 2007 Aug; 25(24):3603-8. PubMed ID: 17704408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of SBRT versus IMRT: an emerging initial radiation treatment option for organ-confined prostate cancer.
    Hodges JC; Lotan Y; Boike TP; Benton R; Barrier A; Timmerman RD
    Am J Manag Care; 2012 May; 18(5):e186-93. PubMed ID: 22694113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of intensity-modulated radiotherapy in oropharyngeal cancer.
    Yong JH; Beca J; O'Sullivan B; Huang SH; McGowan T; Warde P; Hoch JS
    Clin Oncol (R Coll Radiol); 2012 Sep; 24(7):532-8. PubMed ID: 22739256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the Cost-Effectiveness of Hydrogel Rectal Spacer in Prostate Cancer Radiation Therapy.
    Levy JF; Khairnar R; Louie AV; Showalter TN; Mullins CD; Mishra MV
    Pract Radiat Oncol; 2019 Mar; 9(2):e172-e179. PubMed ID: 30342180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of prostate boost with high-dose-rate brachytherapy versus intensity-modulated radiation therapy in the treatment of intermediate-high risk prostate cancer.
    Vu CC; Blas KG; Lanni TB; Gustafson GS; Krauss DJ
    Brachytherapy; 2018; 17(6):852-857. PubMed ID: 30076108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of proton beam therapy for treatment decision making in paranasal sinus and nasal cavity cancers in China.
    Li G; Qiu B; Huang YX; Doyen J; Bondiau PY; Benezery K; Xia YF; Qian CN
    BMC Cancer; 2020 Jun; 20(1):599. PubMed ID: 32590957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review of the cost effectiveness of radiation therapy for prostate cancer from 2003 to 2013.
    Amin NP; Sher DJ; Konski AA
    Appl Health Econ Health Policy; 2014 Aug; 12(4):391-408. PubMed ID: 25022451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.